Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 Next >
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags LILLY DRN Companies Diabetes
From CNBC.com News
Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds
Tickers NEWS
Tags Markets Top Stories cannabis seniors
From Benzinga
Shark Tank's Barbara Corcoran Reveals Her Struggle With Alzheimer's In Her Family
Tickers NEWS
Tags Barbara Corcoran Benzinga Shark Tank
From Benzinga
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Business Biogen Inc Health care industry
From CNBC.com News
Midsummer News Flashes – Good and Not So Good
Tags C2N Diagnostics Dengue fever Alzheimer's Disease
From Stock Gumshoe
Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update
Tags Parkinson's Disease Doc Gumshoe Alzheimer's Disease
From Stock Gumshoe
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
Tickers ALS NEWS WENA
Tags Benzinga Market News Neurodegenerative Disorder
From Benzinga
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Tickers LLY NEWS
Tags Health Care General Biotech
From Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Asia Markets Market Outlook Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Eli Lilly and Co Tesla Inc Daily Open
From CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
Tags Benzinga Market News Alzheimer’s
From Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
Tags Alzheimer's disease Retirement planning Your Money
From CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags Biotech Briefs News
From Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
Tickers CBD
Tags Benzinga Market News Markets
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Tickers ACIU BIIB ESAIY ESALY
Tags Penny Stocks LLY VAXX
From Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
Tags Health Tips and Wellness Advice Alzheimer's disease Make It / Life
From CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
Tickers TECH
Tags cannabis and autism Tech PTSD cannabis
From Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
Tags Podcasting Alzheimer's disease Make It / Success
From CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
Tickers POTX TOKE
Tags Alzheimer's disease Inc/ Biotech
From Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
Tags Retirement Health care costs Elder care insurance
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Social issues US: News U/S/ Economy
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Health care industry Business Biogen Inc
From CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
Tickers ALZN BIIB LLY SAVA
Tags Biotech Small Cap Alzheimer's disease
From Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags US: News Social issues Policy
From CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
Tags Migraine atrial fibrillation Mammogram
From Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
Tags Benzinga Market News Cannabis
From Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Health care industry Biogen Inc Business
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
Tags US Economy Social issues US: News
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Politics U/S/ Economy Health & Science
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.